Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling

Recent data has shown that cyclin G2 (CCNG2) is an atypical cyclin that inhibits cell cycle progression and is often dysregulated in human cancers. The involvement of cyclin G2 in the occurrence and development of diabetic nephropathy (DN) has not been determined. In the present study, we conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chenyang, Gao, Jinlan, Li, Sen, Liu, Qi, Hou, Xiaoyu, Liu, Shenghuan, Xing, Xuesha, Sun, Manni, Wang, Shusen, Luo, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215590/
https://www.ncbi.nlm.nih.gov/pubmed/30420966
http://dx.doi.org/10.1155/2018/6938482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215590/
https://www.ncbi.nlm.nih.gov/pubmed/30420966
http://dx.doi.org/10.1155/2018/6938482

Ejemplares similares